The Ohio State University Heart and Vascular Center’s Structural Heart Disease Program is a leader in providing patients with heart valve disease access to the newest and most advanced treatments. Ohio State is one of only a handful of centers in Ohio offering Transcatheter Aortic Valve Replacement (TAVR) for aortic valve regurgitation stenosis. We are currently participating in a variety of clinical trials evaluating groundbreaking therapies in patients with structural heart disease.
Our dedicated program for Structural Heart Disease offers you access to the most advanced treatments and options for every condition. We have assembled a team of experts including interventional cardiologists, cardiac surgeons, dedicated nursing staff and other specialists, to ensure you receive the most comprehensive care available, often quickly as part of a one-step evaluation process.